BD SurePath™ Pap Test

Highest disease detection in the industry

Lowest Unsat rate in the industry

Low ASC-US rates¹

And now, BD SurePath™ Liquid-based Pap test is FDA-approved for out-of-vial CT/GC testing!

Now physicians can have the convenience of FDA-approved one-vial testing for cervical cancer, Chlamydia and Gonorrhea with very accurate results.

When you use the BD SurePath™ Liquid-based Pap test in conjunction with the BD ProbeTec™ CT/GC Q^xAmplified DNA assays for testing for Chlamydia trachomatis (CT) and Neisseria Gonorrhoeae (GC), you get the convenience and reliable test results you’ve come to expect from BD Diagnostics.

Why use BD ProbeTec™ CT/GC Assays?

Higher sensitivity

Competitive specificity

Fewer rejected samples due to blood, mucus, gels, or cell debris

One-vial testing. Convenient for physicians. More comfortable for patients

Minimal specimen volume

The only assays approved by the FDA for use with BD SurePath™ test


(Click for larger image)

^{* BD ProbeTec™ Chlamydia trachomatis Q^x Amplified DNA Assay Package Insert 8081408 ** BD ProbeTec™ Neisseria gonorrhoeae Q^x Amplified DNA Assay Package Insert 8081400}

For further information on using BD SurePath™ samples for CT/GC testing, contact your local BD representative or refer to the following package inserts:

BD SurePath™ Liquid-based Pap Test Product Insert (English)

BD PrepStain™ System Product Insert (English)

Release Notes (English)

^References:
^{1 See BD PrepStain™ System Product Insert}